File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1021/acs.biomac.1c00281
- Scopus: eid_2-s2.0-85108550191
- PMID: 34097404
- WOS: WOS:000674171500010
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Direct Injection of Hydrogels Embedding Gold Nanoparticles for Local Therapy after Spinal Cord Injury
Title | Direct Injection of Hydrogels Embedding Gold Nanoparticles for Local Therapy after Spinal Cord Injury |
---|---|
Authors | |
Issue Date | 2021 |
Citation | Biomacromolecules, 2021, v. 22, n. 7, p. 2887-2901 How to Cite? |
Abstract | In this study, we created a hydrogel composed of glycol chitosan (gC) and oxidized hyaluronate (oHA). Gold nanoparticles (GNPs) were conjugated with ursodeoxycholic acid (UDCA). The GNP-UDCA complex was embedded into gC-oHA (CHA) hydrogels to form a CHA-GNP-UDCA gel. This CHA-GNP-UDCA gel was injected once into an epicenter of an injured region in SCI rats. Near-infrared (NIR) irradiation was then applied to the lesion as a means of local therapy. To optimize the viscosity for injection into a lesion, several volume ratios of gC and oHA were investigated using scanning electron microscopy and a rotating rheometer. The optimally synthesized CHA-GNP-UDCA gel under NIR irradiation suppressed the production of inflammatory cytokines in vitro. In addition, the optimized CHA-GNP-UDCA gel under NIR irradiation inhibited the cystic cavity of the lesion and significantly improved the hindlimb function. The production of inflammatory cytokines following SCI was significantly inhibited in the CHA-GNP-UDCA gel + NIR group. CHA-GNP-UDCA gels with NIR irradiation can therefore have therapeutic effects for those with spinal cord injuries. |
Persistent Identifier | http://hdl.handle.net/10722/324185 |
ISSN | 2023 Impact Factor: 5.5 2023 SCImago Journal Rankings: 1.232 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ko, Wan Kyu | - |
dc.contributor.author | Lee, Sang Jin | - |
dc.contributor.author | Kim, Seong Jun | - |
dc.contributor.author | Han, Gong Ho | - |
dc.contributor.author | Han, In Bo | - |
dc.contributor.author | Hong, Je Beom | - |
dc.contributor.author | Sheen, Seung Hun | - |
dc.contributor.author | Sohn, Seil | - |
dc.date.accessioned | 2023-01-13T03:02:05Z | - |
dc.date.available | 2023-01-13T03:02:05Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Biomacromolecules, 2021, v. 22, n. 7, p. 2887-2901 | - |
dc.identifier.issn | 1525-7797 | - |
dc.identifier.uri | http://hdl.handle.net/10722/324185 | - |
dc.description.abstract | In this study, we created a hydrogel composed of glycol chitosan (gC) and oxidized hyaluronate (oHA). Gold nanoparticles (GNPs) were conjugated with ursodeoxycholic acid (UDCA). The GNP-UDCA complex was embedded into gC-oHA (CHA) hydrogels to form a CHA-GNP-UDCA gel. This CHA-GNP-UDCA gel was injected once into an epicenter of an injured region in SCI rats. Near-infrared (NIR) irradiation was then applied to the lesion as a means of local therapy. To optimize the viscosity for injection into a lesion, several volume ratios of gC and oHA were investigated using scanning electron microscopy and a rotating rheometer. The optimally synthesized CHA-GNP-UDCA gel under NIR irradiation suppressed the production of inflammatory cytokines in vitro. In addition, the optimized CHA-GNP-UDCA gel under NIR irradiation inhibited the cystic cavity of the lesion and significantly improved the hindlimb function. The production of inflammatory cytokines following SCI was significantly inhibited in the CHA-GNP-UDCA gel + NIR group. CHA-GNP-UDCA gels with NIR irradiation can therefore have therapeutic effects for those with spinal cord injuries. | - |
dc.language | eng | - |
dc.relation.ispartof | Biomacromolecules | - |
dc.title | Direct Injection of Hydrogels Embedding Gold Nanoparticles for Local Therapy after Spinal Cord Injury | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1021/acs.biomac.1c00281 | - |
dc.identifier.pmid | 34097404 | - |
dc.identifier.scopus | eid_2-s2.0-85108550191 | - |
dc.identifier.volume | 22 | - |
dc.identifier.issue | 7 | - |
dc.identifier.spage | 2887 | - |
dc.identifier.epage | 2901 | - |
dc.identifier.eissn | 1526-4602 | - |
dc.identifier.isi | WOS:000674171500010 | - |